Epidemiology of Hypertension in the Elderly With Chronic Kidney Disease

Advances in Chronic Kidney Disease

Volumn 17, Issue 4, 2010, Pages 329-340

  Fischer, Michael J ^a   O'Hare, Ann M ^a  

^a JESSE BROWN VA MEDICAL CENTER   (United States)

Author keywords

Aged; Blood pressure; Chronic kidney failure; Geriatrics

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

CHRONIC KIDNEY DISEASE; DIASTOLIC BLOOD PRESSURE; GERIATRIC PATIENT; HUMAN; HYPERTENSION; PREVALENCE; PRIORITY JOURNAL; REVIEW; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; CHRONIC DISEASE; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; HYPERTENSION; KIDNEY DISEASES; MALE; UNITED STATES;

EID: 77953792091     PISSN: 15485595     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ackd.2010.05.003     Document Type: Review

References (56)

1. United States Census Bureau: Available at: www.census.gov/
2. Wolff J.L., Starfield B., and Anderson G. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Int Med 162 (2002) 2269-2276
3. Coresh J., Selvin E., Stevens L.A., et al. Prevalence of chronic kidney disease in the United States. JAMA 298 (2007) 2038-2047
4. O'Hare A.M., Bertenthal D., Covinsky K.E., et al. Mortality risk stratification in chronic kidney disease: One size for all ages?. J Am Soc Nephrol 17 (2006) 846-853
5. U.S. Renal Data System. USRDS 2009: Annual Data Report: Atlas of End-Stage Renal Disease in the United States (2009), National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD
6. Kurella M., Covinsky K.E., Collins A.J., et al. Octogenarians and nonagenarians starting dialysis in the United States. Ann Intern Med 146 (2007) 177-183
7. Burt V.L., Whelton P., Roccella E.J., et al. Prevalence of hypertension in the US adult population: Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 25 (1995) 305-313
8. Barker W.H., Mullooly J.P., and Linton K.L. Trends in hypertension prevalence, treatment, and control in a well defined older population. Hypertension 31 1 Pt 2 (1998) 552-559
9. Franklin S.S., Gustin W., Wong N.D., et al. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation 96 (1997) 308-315
10. Hajjar I., and Kotchen T.A. Trend in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 290 (2003) 199-206
11. Brenner B.M., Garcia D.L., and Anderson S. Glomeruli and blood pressure: Less of one, more the other?. Am J Hypertens 1 (1988) 335-347
12. Cowley Jr. A.W., and Roman R.J. The role of the kidney in hypertension. JAMA 275 (1996) 1581-1589
13. Anderson S., Rennke H.G., and Brenner B.M. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 77 (1986) 1993-2000
14. Law C.M., deSwiet M., Osmond C., et al. Initiation of hypertension in utero and its amplification throughout life. BMJ 306 (1993) 24-27
15. Keller G., Zimmer G., Mall G., et al. Nephron number in patients with primary hypertension. N Engl J Med 348 (2003) 101-108
16. Kestenbaum B., Rudser K.D., deBoer I.H., et al. Differences in kidney function and incident hypertension: The multi-ethnic study of atherosclerosis. Ann Intern Med 148 (2008) 501-508
17. Hsu C.Y., McCulloch C.E., Darbinian J., et al. Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease. Arch Intern Med 165 (2005) 923-928
18. Zhou X.J., Rakheja D., Yu X., et al. The aging kidney. Kidney Int 74 (2008) 710-720
19. Coresh J., Wei G.L., McQuillan G., et al. Prevalence of high blood pressure and elevated serum creatinine level in the United States: Findings from the third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med 161 (2001) 1207-1216
20. Rao M.V., Qui Y., Wang C., et al. Hypertension and CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES), 1999-2004. Am J Kidney Dis 51 Suppl 2 (2008) S30-S37
21. Kalaitzidis R., Li S., Wang C., et al. Hypertension in early-stage kidney disease: An update from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis 53 Suppl 4 (2009) S22-S31
22. Ostchega Y., Dillon C.F., Hughes J.P., et al. Trends in Hypertension prevalence, awareness, treatment, and control in older U.S. adults: Data from the National Health and Nutrition Examination Survey 1988 to 2004. J Am Geriatr Soc 55 (2007) 1056-1065
23. Roderick P.J., Atkins R.J., Smeeth L., et al. CKD and mortality risk in older people: A community-based population study in the United Kingdom. Am J Kidney Dis 53 (2009) 950-960
24. Peralta C.A., Hicks L.S., Chertow G.M., et al. Control of hypertension in adults with chronic kidney disease in the United States. Hypertension 45 (2005) 1119-1124
25. Plantinga L.C., Miller E.R., Stevens L.A., et al. Blood pressure control among persons without and with chronic kidney disease: US trends and risk factors 1999 to 2006. Hypertension 54 (2009) 47-56
26. Sarafidis P.A., Li S., Chen S.C., et al. Hypertension awareness, treatment, and control in chronic kidney disease. Am J Med 121 (2008) 332-340
27. Borzecki A.M., Wong A.T., Hickey E.C., et al. Hypertension control: How well are we doing?. Arch Intern Med 163 (2003) 2705-2711
28. Peralta C.A., Shlipak M.G., Wassel-Fyr C., et al. Association of antihypertensive therapy and diastolic hypotension in chronic kidney disease. Hypertension 50 (2007) 474-480
29. Somes G.W., Pahor M., Shorr R.I., et al. The role of diastolic blood pressure when treating isolated systolic hypertension. Arch Intern Med 159 (1999) 2004-2009
30. Fagard R.H., Staessen J.A., Thijs I., et al. On treatment diastolic blood pressure and prognosis in systolic hypertension. Arch Intern Med 167 (2007) 1884-1891
31. Messerli F.H., Mancia G., Conti R., et al. Dogma disputed: Can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous. Ann Intern Med 144 (2006) 884-893
32. Investigators ONTARGET. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 358 (2008) 52-61
33. Hyman D.J. Pavlik Van: Self-reported hypertension treatment practices among primary care physicians. Arch Intern Med 160 (2000) 2281-2286
34. Oliveria S.A., Lapuerta P., McCarthy B.D., et al. Physician-related barriers to the effective management of uncontrolled hypertension. Arch Intern Med 162 (2002) 413-420
35. Hajjar I., Miller K., and Hirth V. Age-related bias in the management of hypertension: A national survey of physicians' opinions on hypertension in elderly adults. J Gerontol 57 (2002) 487-491
36. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in Elderly Program (SHEP). JAMA 265 (1997) 3255-3264
37. Chobanian A.V., Bakris G.L., Black H.R., et al. The seventh report of the Joint National Committee on prevention, detection, and evaluation and treatment of high blood pressure. Hypertension 42 (2003) 1206-1252
38. Williams B., Poulter N.R., Brown M.J., et al. British Hypertension Society guidelines for management of hypertension: Report of the fourth working party of British Hypertension Society, 2004-BHS IV. J Hum Hypertens 18 (2004) 139-185
39. Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). 2007 guidelines for the management of arterial hypertension. J Hypertens 25 (2007) 1105-1187
40. World Health Organization. 2003 World health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 21 (2003) 1983-1992
41. Canadian Hypertension Education Program. 2007 guidelines for the management of arterial hypertension. Can J Cardiol 23 (2007) 539-559
42. Zanchetti A., Grassi G., and Mancia G. When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical appraisal. J Hypertens 27 (2009) 923-934
43. Zanchetti A., Mancia G., Black H.R., et al. Facts and fallacies of blood pressure control in recent trials: Implications in the management of patients with hypertension. J Hypertens 27 (2009) 673-679
44. Beckett N.S., Peters R., Fletcher A.E., et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 358 (2008) 1887-1898
45. Lindemann R.D. Hypertension and kidney protection in the elderly: What is the evidence in 2007?. Int Urol Nephrol 39 (2007) 669-678
46. Goodwin J.S. Embracing complexity: A consideration of hypertension in the very old. J Gerontol 58 (2003) 653-658
47. Estacio R.O., Jeffers B.W., Hiatt W.R., et al. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension. N Engl J Med 338 (1998) 645-652
48. Schrier R.W., Estacio R.O., Esler A., et al. Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy, and strokes. Kidney Int 61 (2002) 1086-1097
49. Lewis J.B., Berl T., Bain R.P., et al. Effect of intensive blood pressure control on the course of type 1 diabetic nephropathy. Collaborative Study Group. Am J Kidney Dis 34 (1999) 809-817
50. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ 317 (1998) 703-713
51. Reggenenti P., Perna A., Loriga G., et al. Blood pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): Multicentre, randomized, controlled trial. Lancet 365 (2005) 939-946
52. Wright J.T., Bakris G., Greene T., et al. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: Results from the AASK trial. JAMA 288 (2002) 2421-2431
53. Klahr S., Levey A.S., Beck G.J., et al. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med 330 (1994) 877-884
54. Kovesdy C.P., Trivedi B.K., Kalantar-Zadeh K., et al. Association of low blood pressure with increased mortality in patients with moderate to severe chronic kidney disease. Nephrol Dial Transplant 21 (2006) 1257-1262
55. Agarwal R. Blood pressure components and the risk for end-stage renal disease and death in chronic kidney disease. Clin J Am Soc Nephrol 4 (2009) 830-837
56. The ACCORD Study Group: Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Eng J Med (in press)